Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ANNX · against 596 other Healthcare companies listed in US-listed
Ranked #236 of 597 · scores higher than 61% of peers · safety percentile 61
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)35 peers with a safety percentile of 60–69, including ANNX · Click a bar to see the companies
A mix: stronger current ratio and debt / equity, but weaker beta than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | ANNX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 523 reported | 0.13× | 0.23× | 60% | 33% | |
| BetaLower is better · 556 reported | 1.22 | 0.95 | 34% | 33% | |
| Current ratioHigher is better · 600 reported | 5.53× | 3.91× | 61% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 232 | 40.2B USD | 62 | 73 | |
| 233 | 255M USD | 62 | 36 | |
| 234 | 551M USD | 62 | 20 | |
| 235 | 375M USD | 62 | 46 | |
| 236 | 794M USD | 61 | ||
| 237 | 3.4B USD | 61 | 48 | |
| 238 | 1.6B USD | 61 | 48 | |
| 239 | 30M USD | 60 | ||
| 240 | 1.8B USD | 60 | 80 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score